[go: up one dir, main page]

TR200101182T2 - Kuru toz halindeki aktif maddenin akciğere iletimi. - Google Patents

Kuru toz halindeki aktif maddenin akciğere iletimi.

Info

Publication number
TR200101182T2
TR200101182T2 TR2001/01182T TR200101182T TR200101182T2 TR 200101182 T2 TR200101182 T2 TR 200101182T2 TR 2001/01182 T TR2001/01182 T TR 2001/01182T TR 200101182 T TR200101182 T TR 200101182T TR 200101182 T2 TR200101182 T2 TR 200101182T2
Authority
TR
Turkey
Prior art keywords
active substance
lung
dry powder
delivery
powder active
Prior art date
Application number
TR2001/01182T
Other languages
English (en)
Turkish (tr)
Inventor
Clark Andrew
Kuo Mei-Chang
Lalor Cecily
John Aldous Barry
Original Assignee
Inhale Therapeutic Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Systems, Inc. filed Critical Inhale Therapeutic Systems, Inc.
Publication of TR200101182T2 publication Critical patent/TR200101182T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
TR2001/01182T 1998-09-14 1999-09-13 Kuru toz halindeki aktif maddenin akciğere iletimi. TR200101182T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
TR200101182T2 true TR200101182T2 (tr) 2001-09-21

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01182T TR200101182T2 (tr) 1998-09-14 1999-09-13 Kuru toz halindeki aktif maddenin akciğere iletimi.

Country Status (44)

Country Link
EP (1) EP1117442A1 (fr)
JP (1) JP2002524535A (fr)
KR (1) KR20010075063A (fr)
CN (1) CN1317977A (fr)
AP (1) AP1374A (fr)
AR (1) AR022090A1 (fr)
AU (1) AU753014B2 (fr)
BG (1) BG105430A (fr)
BR (1) BR9913722A (fr)
CA (1) CA2343920A1 (fr)
CO (1) CO5130023A1 (fr)
CZ (1) CZ2001829A3 (fr)
DZ (1) DZ2892A1 (fr)
EA (1) EA003476B1 (fr)
EE (1) EE200100151A (fr)
GE (1) GEP20043257B (fr)
GT (1) GT199900156A (fr)
HK (1) HK1042231A1 (fr)
HN (1) HN1999000159A (fr)
HR (1) HRP20010189A2 (fr)
HU (1) HUP0103837A3 (fr)
ID (1) ID28845A (fr)
IL (2) IL141562A0 (fr)
IS (1) IS5878A (fr)
LT (1) LT4897B (fr)
LV (1) LV12658B (fr)
MA (1) MA25590A1 (fr)
MY (1) MY129282A (fr)
NO (1) NO20011251L (fr)
NZ (1) NZ510168A (fr)
OA (1) OA11781A (fr)
PA (1) PA8481901A1 (fr)
PE (1) PE20001061A1 (fr)
PL (1) PL195574B1 (fr)
SA (1) SA99200718B1 (fr)
SK (1) SK3442001A3 (fr)
TN (1) TNSN99173A1 (fr)
TR (1) TR200101182T2 (fr)
TW (1) TWI226248B (fr)
UA (1) UA76085C2 (fr)
UY (1) UY25711A1 (fr)
WO (1) WO2000015262A1 (fr)
YU (1) YU24201A (fr)
ZA (1) ZA200101995B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
JP4874483B2 (ja) 1999-06-09 2012-02-15 ロバート イー. シーバース 超臨界流体補助ネブライゼーション及びバブル乾燥
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (fr) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
CA2465675C (fr) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Compositions particulaires ameliorees destinees a etre administrees par voie pulmonaire
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
UA83341C2 (uk) 2002-02-25 2008-07-10 Дифьюжен Фармасьютикалз Ллк Біополярні солі транс-каротиноїдів та їх використання
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
CA2511385A1 (fr) * 2002-12-19 2004-07-22 Pharmacia Corporation Intermediaire pour formulation a caractere non-hygroscopique acceptable comprenant un bouchon hydroscopique
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
ES2909080T3 (es) 2004-04-23 2022-05-05 Cydex Pharmaceuticals Inc Formulación de DPI que contiene sulfoalquil éter ciclodextrina
US8030350B2 (en) 2005-02-24 2011-10-04 Diffusion Pharmaceuticals Llc Trans carotenoids, their synthesis, formulation and uses
BRPI0608844A2 (pt) * 2005-03-09 2010-02-02 Ono Pharmaceutical Co partìcula e preparação que contém a partìcula
ES2526903T3 (es) 2005-10-26 2015-01-16 Cydex Pharmaceuticals, Inc. Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
KR20090081407A (ko) * 2006-10-25 2009-07-28 다이닛본 스미토모 세이야꾸 가부시끼가이샤 고결 방지 과립상 제제
EP1925295A1 (fr) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Formule de poudre stable contenant un nouveau anticholinergique
MX2009010988A (es) 2007-04-13 2010-03-15 Diffusion Pharmaceuticals Llc Uso de trans-carotenoides bipolares como un tratamiento previo y en el tratamiento de una enfermedad vascular periferica.
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
MX2010004803A (es) 2007-10-31 2010-09-09 Diffusion Pharmaceuticals Llc Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas.
US9610343B2 (en) * 2009-05-20 2017-04-04 Aeras Global Tb Vaccine Foundation Stable, spray dryed, immunogenic, viral compositions
EP2445339B1 (fr) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Composé améliorant la diffusion et son utilisation avec un thrombolytique
ES2654945T3 (es) 2010-06-02 2018-02-15 Diffusion Pharmaceuticals Llc Formulaciones orales de carotenoides trans bipolares
US9682096B2 (en) 2012-05-02 2017-06-20 Janssen R & D Ireland Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (fr) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Poudres pulmonaires de densité ultra basse
WO2015042352A1 (fr) * 2013-09-20 2015-03-26 Virginia Commonwealth University Administration de particules à l'aide d'excipients hygroscopiques
CA2965759C (fr) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Polypeptides en poudre presentant moins d'impuretes de disulfide comprenant des materiaux cationiques divalents
WO2017165667A1 (fr) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Utilisation de caroténoïdes trans bipolaires avec une chimiothérapie et une radiothérapie en vue du traitement d'un cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ATE222754T1 (de) * 1992-06-12 2002-09-15 Teijin Ltd Ultrafeines pulver zur inhalation und dessen herstellung
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1998031346A1 (fr) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation de particules pour inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
UA76085C2 (en) 2006-07-17
IS5878A (is) 2001-03-05
CN1317977A (zh) 2001-10-17
IL141562A0 (en) 2002-03-10
HUP0103837A3 (en) 2002-11-28
CZ2001829A3 (cs) 2001-09-12
KR20010075063A (ko) 2001-08-09
TWI226248B (en) 2005-01-11
PL346768A1 (en) 2002-02-25
EP1117442A1 (fr) 2001-07-25
ZA200101995B (en) 2002-03-11
HUP0103837A2 (hu) 2002-05-29
BG105430A (en) 2001-12-29
AP2001002093A0 (en) 2001-03-31
CO5130023A1 (es) 2002-02-27
MY129282A (en) 2007-03-30
GT199900156A (es) 2001-03-07
WO2000015262A1 (fr) 2000-03-23
HRP20010189A2 (en) 2005-04-30
PE20001061A1 (es) 2000-10-08
IL141562A (en) 2007-07-24
TNSN99173A1 (fr) 2005-11-10
LV12658A (lv) 2001-05-20
SA99200718B1 (ar) 2006-11-04
AR022090A1 (es) 2002-09-04
CA2343920A1 (fr) 2000-03-23
BR9913722A (pt) 2001-05-29
LT2001021A (en) 2001-11-26
PA8481901A1 (es) 2002-04-25
UY25711A1 (es) 1999-11-17
AP1374A (en) 2005-02-28
LT4897B (lt) 2002-02-25
EA003476B1 (ru) 2003-06-26
ID28845A (id) 2001-07-05
LV12658B (lv) 2001-09-20
NO20011251L (no) 2001-04-17
HK1042231A1 (zh) 2002-08-09
SK3442001A3 (en) 2001-11-06
JP2002524535A (ja) 2002-08-06
AU753014B2 (en) 2002-10-03
EE200100151A (et) 2002-06-17
MA25590A1 (fr) 2002-12-31
GEP20043257B (en) 2004-06-25
OA11781A (en) 2005-07-26
DZ2892A1 (fr) 2003-12-15
AU6039799A (en) 2000-04-03
EA200100300A1 (ru) 2001-10-22
NO20011251D0 (no) 2001-03-13
PL195574B1 (pl) 2007-10-31
YU24201A (sh) 2003-08-29
HN1999000159A (es) 1999-11-11
NZ510168A (en) 2003-09-26

Similar Documents

Publication Publication Date Title
TR200101182T2 (tr) Kuru toz halindeki aktif maddenin akciğere iletimi.
EA200301275A1 (ru) Капсулы для ингаляции
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
NO921791L (no) Nikotininneholdende, stimulerende enhet
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
BR9607260A (pt) Utilização de aerogéis em agricultura
AR028315A2 (es) Compuestos de 1-arilpirazolcarboxaldehidos hidrazonas de plagas de actividad sistemica en la represion de plagas de artropodos, helmintos, nematodoss y protozoos; procedimientos para prepararlos y composiciones plaguicidas que lo contienen, y metodos de aplicacion de dichos compuestos para la repres
IT1208208B (it) Copolimeri solubili e biodegradabili per legare sostanze biologicamente attive.
ES2058151T3 (es) Complejos de saponinas con fosfolipidos y composiciones farmaceuticas y cosmeticas que los contienen.
EE05620B1 (et) Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid
ATE210975T1 (de) Topisch anzuwendende zubereitungen enthaltend n- acetyl-l-cystein
GR1000272B (el) Συνεργικες μυκητοκτονες και ακαρεοκτονες συνθεσεις περιεχουσες δυο η τρια δραστικα συστατικα.
ATE58639T1 (de) Appetit mildernde und gegen gastritis wirksame zusammensetzung.
FI812859A7 (fi) Uudet karboksialkyyli-peptidit ja peptidien tioeetterit ja eetterit verenpainetta alentavina aineina.
FI840428A7 (fi) Biologisesti aktiivinen ketoni- johdannainen, sen valmistus ja käyttö.
DK0665714T3 (da) Granulære vandopløselige eller hygroskopiske landbrugsformuleringer og fremgangsmåder til fremstilling heraf
EP1211311A3 (fr) Lymphocytes activés issus du sang de cordon ombilical et compositions contenant ces lymphocytes
IT8919975A0 (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
UA39899C2 (uk) Спосіб приготування сухого сипучого порошку ацифлуорфену або його агротехнічно придатних солей (варіанти), приготований таким способом сухий сипучий порошок (варіанти) та пва-пакет, що містить cухий сипучий порошок (варіанти)
NO20003888L (no) Anti-enzympreparater omfattende etylendiamindiravsyre
TR200002118T2 (tr) Baldırdaki ülserlerin ve dekubitik ülserlerin tedavisinde pudra müstahzarlarının kullanılması.
AR004744A1 (es) Mezclas fungicidas, procedimiento para combatir hongos nocivos con dichas mezclas y procedimiento para preparar dichas mezclas fungicidas
BG40951A3 (en) Herbicide means
NL188891C (nl) Farmaceutisch preparaat met bloeddrukverlagende werking dat co-dergocrine en nog een actief materiaal bevat.
FI844610A7 (fi) Pyridyyliasetonitriilijohdannaiset, niiden valmistus ja käyttö maanviljelyksessä fungisideina.